These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 6975270

  • 1. C-19393 S2 and H2, new carbapenem antibiotics. IV. Inhibitory activity against beta-lactamases.
    Okonogi K, Nozaki Y, Imada A, Kuno M.
    J Antibiot (Tokyo); 1981 Feb; 34(2):212-7. PubMed ID: 6975270
    [Abstract] [Full Text] [Related]

  • 2. Beta-lactamase inhibitory activities and synergistic effects of 5,6-cis-carbapenem antibiotics.
    Okonogi K, Harada S, Shinagawa S, Imada A, Kuno M.
    J Antibiot (Tokyo); 1982 Aug; 35(8):963-71. PubMed ID: 6982889
    [Abstract] [Full Text] [Related]

  • 3. Combined antibacterial activity of amoxicillin with clavulanic acid against ampicillin-resistant strains.
    Matsuura M, Nakazawa H, Hashimoto T, Mitsuhashi S.
    Antimicrob Agents Chemother; 1980 Jun; 17(6):908-11. PubMed ID: 6967713
    [Abstract] [Full Text] [Related]

  • 4. Antimicrobial and beta-lactamase inhibitory activities of carpetimycins A and B, new carbapenem antibiotics.
    Kobayashi F, Saino Y, Koshi T, Hattori Y, Nakayama M, Iwasaki A, Mori T, Mitsuhashi S.
    Antimicrob Agents Chemother; 1982 Apr; 21(4):536-44. PubMed ID: 6979308
    [Abstract] [Full Text] [Related]

  • 5. In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam.
    Muratani T, Yokota E, Nakane T, Inoue E, Mitsuhashi S.
    J Antimicrob Chemother; 1993 Sep; 32(3):421-9. PubMed ID: 8262864
    [Abstract] [Full Text] [Related]

  • 6. In vitro antibacterial activities of ticarcillin alone and ticarcillin plus clavulanic acid against beta-lactamase producing and non-producing microorganisms.
    Hsueh PR, Chang SC, Chen YC, Hsu LY, Luh KT, Hsieh WC.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Aug; 25(3):149-59. PubMed ID: 1342000
    [Abstract] [Full Text] [Related]

  • 7. In-vitro evaluation of ampicillin/brobactam and comparison with other beta-lactam antibiotics.
    Melchior NH, Keiding J.
    J Antimicrob Chemother; 1991 Jan; 27(1):29-40. PubMed ID: 1646779
    [Abstract] [Full Text] [Related]

  • 8. Combination beta-lactam and beta-lactamase-inhibitor products: antimicrobial activity and efficiency of enzyme inhibition.
    Rotschafer JC, Ostergaard BE.
    Am J Health Syst Pharm; 1995 Mar 15; 52(6 Suppl 2):S15-22. PubMed ID: 7606585
    [Abstract] [Full Text] [Related]

  • 9. Comparative inhibition beta-lactamases by novel beta-lactam compounds.
    Fu KP, Neu HC.
    Antimicrob Agents Chemother; 1979 Feb 15; 15(2):171-6. PubMed ID: 311616
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z, Kayacan C, Oncul O.
    Int J Antimicrob Agents; 2012 Jan 15; 39(1):86-9. PubMed ID: 22041508
    [Abstract] [Full Text] [Related]

  • 11. Cefoxitin, N-formimidoyl thienamycin, clavulanic acid, and penicillanic acid sulfone as suicide inhibitors for different types of beta-lactamases produced by gram-negative bacteria.
    Sawai T, Tsukamoto K.
    J Antibiot (Tokyo); 1982 Nov 15; 35(11):1594-602. PubMed ID: 6298169
    [Abstract] [Full Text] [Related]

  • 12. C-19393 S2 and H2, new carbapenem antibiotics. I. Taxonomy of the producing strain, fermentation and antibacterial properties.
    Imada A, Nozaki Y, Kintaka K, Okonogi K, Kitano K, Harada S.
    J Antibiot (Tokyo); 1980 Dec 15; 33(12):1417-24. PubMed ID: 6788739
    [Abstract] [Full Text] [Related]

  • 13. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
    Yoshida T, Tateda E, Hiramatsu K, Yokota T.
    Jpn J Antibiot; 1996 Apr 15; 49(4):324-37. PubMed ID: 8786624
    [Abstract] [Full Text] [Related]

  • 14. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Kuzucu C, Yetkin F, Görgeç S, Ersoy Y.
    Mikrobiyol Bul; 2011 Jan 15; 45(1):28-35. PubMed ID: 21341156
    [Abstract] [Full Text] [Related]

  • 15. Contribution of beta-lactamases to bacterial resistance and mechanisms to inhibit beta-lactamases.
    Neu HC.
    Am J Med; 1985 Nov 29; 79(5B):2-12. PubMed ID: 3907341
    [Abstract] [Full Text] [Related]

  • 16. Beta-lactamase stability and inhibitory activity of meropenem combined with a potent antibacterial activity.
    Nouda H, Harabe ET, Sumita Y, Okuda T, Fukasawa M.
    Chemotherapy; 1992 Nov 29; 38(4):218-24. PubMed ID: 1473360
    [Abstract] [Full Text] [Related]

  • 17. In-vitro activity and beta-lactamase stability and inhibitory properties of a new penem antibiotic, Sch 34343.
    Neu HC, Chin NX, Labthavikul P.
    J Antimicrob Chemother; 1985 Jun 29; 15 Suppl C():25-37. PubMed ID: 3875603
    [Abstract] [Full Text] [Related]

  • 18. Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.
    Reading C, Cole M.
    Antimicrob Agents Chemother; 1977 May 29; 11(5):852-7. PubMed ID: 879738
    [Abstract] [Full Text] [Related]

  • 19. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E.
    Acta Med Croatica; 2004 May 29; 58(4):307-12. PubMed ID: 15700687
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.